TSS
AMRX icon

Two Sigma Securities’s Amneal Pharmaceuticals AMRX Stock Holding History

Two Sigma Securities’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,582
Closed -$88K – 1654
2024
Q3 		$88K Buy
+10,582
New +$82.7K ﹤0.01% 2301
2023
Q1 		– Sell
-29,803
Closed -$59.3K – 2617
2022
Q4 		$59.3K Buy
29,803
+5,727
+24% +$12.8K ﹤0.01% 2137
2022
Q3 		$49K Buy
+24,076
New +$67.5K ﹤0.01% 2183
2022
Q2 		– Sell
-14,392
Closed -$60K – 2185
2022
Q1 		$60K Buy
+14,392
New +$63.7K ﹤0.01% 1855

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Two Sigma Securities's AMRX Position: Q4 2024 in Review

Two Sigma Securities sold out of Amneal Pharmaceuticals (AMRX) in Q4 2024, closing a stake of 10,582 shares — an estimated $88K sold.

Two Sigma Securities first reported a position in AMRX in Q1 2022 and held it in 4 quarters. The position peaked at $88K in Q3 2024. 199 funds tracked by Wall St. Rank hold AMRX as of Q4 2024.

  • Two Sigma Securities reported no remaining Amneal Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Securities sold 10,582 Amneal Pharmaceuticals shares in Q4 2024, an estimated $88K.
  • Two Sigma Securities first reported a position in Amneal Pharmaceuticals in Q1 2022 and held it in 4 quarters.
  • Two Sigma Securities's Amneal Pharmaceuticals position peaked at $88K in Q3 2024.
  • 199 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.